Zobrazeno 1 - 6
of 6
pro vyhledávání: '"mpa/dmba-driven mammary carcinomas"'
Autor:
Giulia Petroni, Lorenzo Galluzzi
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Radiation therapy (RT) and cyclin-dependent kinase 4/6 (CDK4/6) inhibitors mediate poorly overlapping cytostatic and immunostimulatory effects, suggesting that combinatorial regimens may enable supra-additive tumor control. Our preclinical findings d
Externí odkaz:
https://doaj.org/article/0089cac6adef4f789adc840385262058
Autor:
Takahiro Yamazaki, Erik Wennerberg, Michal Hensler, Aitziber Buqué, Jeffrey Kraynak, Jitka Fucikova, Xi Kathy Zhou, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria, Lorenzo Galluzzi
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
LTX-315 is a nonameric oncolytic peptide in early clinical development for the treatment of solid malignancies. Preclinical and clinical evidence indicates that the anticancer properties of LTX-315 originate not only from its ability to selectively k
Externí odkaz:
https://doaj.org/article/26e51e80d5d54275a28570327a2e04cd
Autor:
Aitziber Buqué, Erik Wennerberg, Baldur Sveinbjørnsson, Jeffrey Kraynak, Lorenzo Galluzzi, Michal Hensler, Sandra Demaria, Øystein Rekdal, Xi Kathy Zhou, Jitka Fucikova, Takahiro Yamazaki
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
LTX-315 is a nonameric oncolytic peptide in early clinical development for the treatment of solid malignancies. Preclinical and clinical evidence indicates that the anticancer properties of LTX-315 originate not only from its ability to selectively k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d89d84694dfd2d7e399d90249b3a47
https://doaj.org/article/26e51e80d5d54275a28570327a2e04cd
https://doaj.org/article/26e51e80d5d54275a28570327a2e04cd
Autor:
Lorenzo Galluzzi, Giulia Petroni
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Oncoimmunology
article-version (VoR) Version of Record
Oncoimmunology
article-version (VoR) Version of Record
Radiation therapy (RT) and cyclin-dependent kinase 4/6 (CDK4/6) inhibitors mediate poorly overlapping cytostatic and immunostimulatory effects, suggesting that combinatorial regimens may enable supra-additive tumor control. Our preclinical findings d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53d8b8d5c78dfe93e5c0681a160b32d
https://doaj.org/article/0089cac6adef4f789adc840385262058
https://doaj.org/article/0089cac6adef4f789adc840385262058
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.